Tag:

Medicare

Latest Headlines

Latest Headlines

Valeant chief calls on Medicare to allow controversial copay help from pharma

Drug companies can't currently help Medicare patients pay for out-of-pocket drug costs. But Valeant, which has come under the lens for its price-hike strategy, wants to change that.

Big Pharma's steady double-digit price hikes cost Medicare billions

A new report from the Center for Medicare and Medicaid Services highlights some commonly used meds whose sales growth--and Medicare spending--depends more on rising prices than on rising demand.

What difference does bargaining make to drug prices? In Norway, up to 58% off

For some perspective on how much more the U.S. pays for drugs than other developed countries, take a look at Norway. U.S. Medicare drug prices were higher for 93% of the top 40 branded meds available in both the U.S. and Norway during the third quarter of 2015, according to a new report from The Wall Street Journal, which looked at why prices are higher in the U.S. than in other developed countries.

Omada Health trumpets promising results from study of digital health program in Medicare patients

Omada Health has revealed promising results from a study that looked at how well its digital health tools could help spur weight loss among Medicare members, a milestone for the company a couple of months after it roped in new funding to develop its health management program.

Myriad inks coverage deal for prostate cancer test

Myriad Genetics has inked a three-year contract with Tufts Health Plan to provide its Prolaris biopsy test for members diagnosed with localized prostate cancer.

Myriad inks coverage deal for prostate cancer test

Myriad Genetics has inked a three-year contract with Tufts Health Plan to provide its Prolaris biopsy test for members diagnosed with localized prostate cancer.

Top-selling drugs might be first in line for Medicare price negotiations

Should Medicare be allowed to square off with pharma on drug prices? Presidential candidate Hillary Clinton was the latest politician to propose it, joining Democratic rival Sen. Bernie Sanders, President Obama--and a variety of other lawmakers before them.

Report: Cancer drug spending fuels large increases in Medicare discount drug program

Cancer drug spending has drawn the ire of payers, patients and doctors unhappy with skyrocketing costs for the meds. Now another voice is joining the chorus of naysayers, as a new report from a cancer community nonprofit organization found that a government discount drug program is profiting off the rising costs of cancer meds.

Myriad snags Medicare coverage for prostate cancer test

Myriad Genetics nabbed Medicare coverage for its prostate cancer screening test, a win for the company as it struggles with waning revenues and increased competition from rivals in the genetic testing market.

Myriad snags Medicare coverage for prostate cancer test

Myriad Genetics nabbed Medicare coverage for its prostate cancer screening test, a win for the company as it struggles with waning revenues and increased competition from rivals in the genetic testing market.